Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

David Rubin
Video
David Rubin, MD, on JAK Inhibitors: Small But Mighty
07/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
07/22/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Gil Melmed
Conference Coverage
Gil Y. Melmed, MD, on the New Wave: Anti-Interleukins in IBD
07/22/2023
Dr Melmed evaluates key efficacy and safety data for interleukin -12/23 and -23 inhibitors for the management of IBD from his presentation at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Melmed evaluates key efficacy and safety data for interleukin -12/23 and -23 inhibitors for the management of IBD from his presentation at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Melmed evaluates key efficacy...
07/22/2023
Advances in Inflammatory Bowel Disease Network
Christina Ha
Video
Christina Ha, MD, on Pregnancy and IBD
07/22/2023
Dr Ha reviews the key points from her presentation on fertility, pregnancy, and breastfeeding for patients with inflammatory bowel disease, which she delivered at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Ha reviews the key points from her presentation on fertility, pregnancy, and breastfeeding for patients with inflammatory bowel disease, which she delivered at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Ha reviews the key points...
07/22/2023
Advances in Inflammatory Bowel Disease Network
Freddy Caldera, DO
Conference Coverage
Freddy Caldera, DO, on the HERCULES Study of Vaccines Among IBD Patients
06/28/2023
Dr Caldera, from the University of Wisconsin, reviews results of the HERCULES study assessing immunological response to vaccines among patients with inflammatory bowel disease.
Dr Caldera, from the University of Wisconsin, reviews results of the HERCULES study assessing immunological response to vaccines among patients with inflammatory bowel disease.
Dr Caldera, from the University...
06/28/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Jess Allegretti
Video
Jessica Allegretti, MD, on the QUASAR Study in Ulcerative Colitis
06/13/2023
Dr Allegretti reviews the results of the phase 3 QUASAR trial of the interleukin-23 inhibitor guselkumab in ulcerative colitis.
Dr Allegretti reviews the results of the phase 3 QUASAR trial of the interleukin-23 inhibitor guselkumab in ulcerative colitis.
Dr Allegretti reviews the...
06/13/2023
Advances in Inflammatory Bowel Disease Network
Ashwin
Conference Coverage
Ashwin Ananthakrishnan, MD, MPH, on Diet as a Risk Factor in IBD
06/09/2023
Dr Ananthakrishnan, from Massachusetts General Hospital in Boston, reviews data from prospective studies on how diet can increase the risk of developing inflammatory bowel disease.
Dr Ananthakrishnan, from Massachusetts General Hospital in Boston, reviews data from prospective studies on how diet can increase the risk of developing inflammatory bowel disease.
Dr Ananthakrishnan, from...
06/09/2023
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Video
Maia Kayal, MD, on Inflammatory and Functional Pouch Disorders
06/07/2023
Dr Kayal, from the Icahn School of Medicine at Mt Sinai, discusses her presentation from Digestive Disease Week on complications of the pouch among patients who have undergone ileal pouch anal anastamosis.
Dr Kayal, from the Icahn School of Medicine at Mt Sinai, discusses her presentation from Digestive Disease Week on complications of the pouch among patients who have undergone ileal pouch anal anastamosis.
Dr Kayal, from the Icahn School...
06/07/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Jessica Allegretti
Video
Jessica Allegretti, MD, on Harnessing S1P Receptor Modulators for IBD Management
05/22/2023
Dr Allegretti reviews her presentation at the Advances in Inflammatory Bowel Disease regional meeting on how to position sphingostine 1-phosphate receptor modulators to optimize patient care in IBD.
Dr Allegretti reviews her presentation at the Advances in Inflammatory Bowel Disease regional meeting on how to position sphingostine 1-phosphate receptor modulators to optimize patient care in IBD.
Dr Allegretti reviews her...
05/22/2023
Advances in Inflammatory Bowel Disease Network
Alan Moss, MD
Conference Coverage
Alan Moss, MD, on JAK Inhibitors: Small But Mighty
05/20/2023
Dr Moss recaps his presentation on the safety and efficacy of Janus kinase inhibitors in the treatment of inflammatory bowel disease from the AIBD regional meeting.
Dr Moss recaps his presentation on the safety and efficacy of Janus kinase inhibitors in the treatment of inflammatory bowel disease from the AIBD regional meeting.
Dr Moss recaps his presentation...
05/20/2023
Advances in Inflammatory Bowel Disease Network
Alan Moss, MD
Conference Coverage
Alan Moss, MD, on Strategies to Optimize Outcomes in Luminal Crohn Disease
05/19/2023
Dr Moss, from Boston University, reviewed 3 key steps in optimizing care for patients with luminal Crohn disease during his presentation at the Advances in Regional Bowel Diseases regional meeting.
Dr Moss, from Boston University, reviewed 3 key steps in optimizing care for patients with luminal Crohn disease during his presentation at the Advances in Regional Bowel Diseases regional meeting.
Dr Moss, from Boston University,...
05/19/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Advertisement

Latest News

News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024

Jolynn Tumolo

Jolynn Tumolo
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Shows Efficacy Among Biologic-Exposed Patients With Crohn’s Disease
09/24/2024
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed...
09/24/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Guselkumab for Moderate to Severe Ulcerative Colitis
09/12/2024
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab...
09/12/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/29/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/29/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Requires Warning Label Change for Thiopurines
08/13/2024
The agency stated that rare cases of intrahepatic cholestasis of pregnancy have been reported among pregnant patients treated with thiopurines for inflammatory bowel disease and systemtic lupus erythematosus.
The agency stated that rare cases of intrahepatic cholestasis of pregnancy have been reported among pregnant patients treated with thiopurines for inflammatory bowel disease and systemtic lupus erythematosus.
The agency stated that rare...
08/13/2024
Advances in Inflammatory Bowel Disease Network
News
MM-SES-CD and SES-CD Threshold Scores and Risk of Disease Progression
08/12/2024
Achieving multiplier Simple Endoscopic Score for Crohn’s Disease
Achieving multiplier Simple Endoscopic Score for Crohn’s Disease
Achieving multiplier Simple...
08/12/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib vs Tofacitinib for Clinical Remission in Ulcerative Colitis
08/09/2024
Investigators conducted a head-to-head trial of the 2 JAK inhibitors to determine which performed best in achieving steroid-free clinical remission among patients with ulcerative colitis
Investigators conducted a head-to-head trial of the 2 JAK inhibitors to determine which performed best in achieving steroid-free clinical remission among patients with ulcerative colitis
Investigators conducted a...
08/09/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Jordan Axelrad, MD, on IBD and Malignancy
08/19/2024
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr...
08/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use